With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Telomeres and Telomerase in Pediatric Acute Myeloid Leukemia||Baylor College of Medicine / Maria Gramatges||Young Investigator Grants||2011||Texas|
|STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML||Baylor College of Medicine / Michele Redell, M.D./Ph.D.||Springboard Grants||2014||Texas|
|Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma||Baylor College of Medicine / Robin Parihar, MD/PhD||'A' Award Grants||2021||Texas|
|Mechanisms of LYL1-associated T-ALL development||Baylor College of Medicine / Margaret Goodell, PhD||Innovation Grants||2012||Texas|
|DICER1-Driven Cancers: Models, Mechanisms and Therapies||University of Texas Southwestern Medical Center at Dallas / James Amatruda, MD/PhD||Innovation Grants||2016||Texas|
|Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma||University of Texas Southwestern Medical Center / Genevieve Kendall, PhD||Young Investigator Grants||2015||Texas|
|V alpha-invariant NKT cells as a novel platform for cancer immunotherapy||Baylor College of Medicine / Leonid Metelitsa, MD, PhD||Innovation Grants||2012||Texas|
|Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene||Baylor College of Medicine / Robin Parihar, MD, PhD||Young Investigator Grants||2015||Texas|
|B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers||University of Texas Southwestern Medical Center / James Amatruda, MD, PhD||Reach Grants||2013||Texas|